Literature DB >> 31599749

Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.

Flora Poon1, Eleni Ieremia2, Graham Collins3, Rubeta N Matin1.   

Abstract

Cutaneous manifestations of Epstein-Barr virus (EBV)-driven B-cell lymphoid proliferations occur rarely as a result of severe immunodeficiency. To date, only a few cases of extranodal EBV-associated B-cell lymphomas arising in patients with angioimmunoblastic T-cell lymphoma (AITL) have been reported, and less common is a cutaneous presentation. AITL is a rare aggressive tumor that carries a poor prognosis and prompt diagnosis, and recognition of EBV-associated diffuse B-cell lymphoma is essential in these patients to instigate the correct treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31599749     DOI: 10.1097/DAD.0000000000001371

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.

Authors:  Marc Grossman; Jia Ruan; Cynthia Magro
Journal:  JAAD Case Rep       Date:  2022-05-13

2.  Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Authors:  Pan Hu; Yu Ben; Juan Liu; Weicheng Zheng; Xiyue Yan; Yaping Zhang; Wenyu Shi
Journal:  Onco Targets Ther       Date:  2021-04-12       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.